
Multiple sclerosis zzso is a chronic zzso inflammatory zzso disease of the central nervous zzso zzso zzso has been used as the first line therapy for zzso treatment in Japan, but patients treated with zzso may develop zzso known as zzso zzso zzso which abrogate its therapeutic zzso zzso zzso zzso and subcutaneous zzso zzso are currently available in Japan, but large-scale studies evaluating the prevalence and clinical implications of zzso against these zzso preparations in zzso patients have only been performed in Caucasian zzso zzso zzso has been reported to be associated with zzso zzso suggesting that the zzso might differ among populations with distinct genetic zzso Clinical information and zzso were collected from 229 consecutive zzso patients treated with zzso in 4 centers in zzso zzso were tested for zzso using a zzso reporter gene zzso In total, zzso of zzso patients zzso and zzso of zzso patients zzso were positive for zzso The frequency of zzso was highest in patients treated for 13 to 24 zzso Clinical zzso and zzso zzso in the magnetic resonance imaging increased together with zzso zzso in this zzso In conclusion, the prevalence of zzso in Japanese zzso patients is similar to that in Caucasian populations and is associated with an increase in disease zzso zzso routine zzso testing is recommended also in Asian populations to ensure the early identification of patients who would benefit from a change in zzso 

